ID30448A - Sel induk hibrid manusia untuk mengekspresikan gen mamalia - Google Patents
Sel induk hibrid manusia untuk mengekspresikan gen mamaliaInfo
- Publication number
- ID30448A ID30448A IDW00200101235A ID20011235A ID30448A ID 30448 A ID30448 A ID 30448A ID W00200101235 A IDW00200101235 A ID W00200101235A ID 20011235 A ID20011235 A ID 20011235A ID 30448 A ID30448 A ID 30448A
- Authority
- ID
- Indonesia
- Prior art keywords
- cells
- human
- recombinant
- genes
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/209,920 US6136599A (en) | 1998-12-10 | 1998-12-10 | Human hybrid host cell for mammalian gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
ID30448A true ID30448A (id) | 2001-12-06 |
Family
ID=22780882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW00200101235A ID30448A (id) | 1998-12-10 | 1999-12-08 | Sel induk hibrid manusia untuk mengekspresikan gen mamalia |
Country Status (27)
Country | Link |
---|---|
US (1) | US6136599A (sl) |
EP (1) | EP1137768B1 (sl) |
JP (3) | JP4332300B2 (sl) |
KR (1) | KR100627753B1 (sl) |
CN (1) | CN1230532C (sl) |
AT (1) | ATE306547T1 (sl) |
AU (1) | AU757188B2 (sl) |
BG (1) | BG65263B1 (sl) |
BR (1) | BRPI9916095B8 (sl) |
CA (1) | CA2353698C (sl) |
CU (2) | CU23382A3 (sl) |
CZ (1) | CZ302677B6 (sl) |
DE (1) | DE69927707T2 (sl) |
DK (1) | DK1137768T3 (sl) |
ES (1) | ES2249929T3 (sl) |
HU (1) | HU229775B1 (sl) |
ID (1) | ID30448A (sl) |
IL (2) | IL143351A0 (sl) |
NO (1) | NO330548B1 (sl) |
PL (1) | PL205549B1 (sl) |
RO (1) | RO121563B1 (sl) |
RU (1) | RU2228355C2 (sl) |
SI (1) | SI20693B (sl) |
SK (1) | SK287888B6 (sl) |
TR (1) | TR200101642T2 (sl) |
UA (1) | UA77642C2 (sl) |
WO (1) | WO2000034462A1 (sl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6358703B1 (en) | 1998-12-10 | 2002-03-19 | Bayer Corporation | Expression system for factor VIII |
US6136599A (en) * | 1998-12-10 | 2000-10-24 | Bayer Corporation | Human hybrid host cell for mammalian gene expression |
US6348192B1 (en) * | 1999-05-11 | 2002-02-19 | Bayer Corporation | Interleukin-2 mutein expressed from mammalian cells |
US20040235715A1 (en) * | 1999-11-12 | 2004-11-25 | Bayer Corporation | Method of producing glycosylated bikunin |
US6569657B1 (en) * | 2000-06-27 | 2003-05-27 | Millennium Pharmaceuticals, Inc. | 32140, a novel human aldehyde dehydrogenase and uses therefor |
US7094587B2 (en) * | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
MY139948A (en) * | 2000-09-28 | 2009-11-30 | Bayer Corp | Enhanced transfection system |
US7723102B2 (en) * | 2000-09-28 | 2010-05-25 | Bayer Corporation | Enhanced transfection system |
US20060073141A1 (en) * | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
KR100496861B1 (ko) | 2002-09-26 | 2005-06-22 | 삼성전자주식회사 | 하나의 핸들러에 2개 이상의 테스트 보드를 갖는 테스트장비 및 그 테스트 방법 |
AU2003298816C1 (en) | 2002-12-02 | 2010-12-16 | Amgen Fremont, Inc. | Antibodies directed to Tumor Necrosis Factor and uses thereof |
US7244616B2 (en) | 2003-06-27 | 2007-07-17 | Bayer Pharmaceuticals Corporation | Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
HUE033776T2 (en) | 2004-11-12 | 2018-01-29 | Bayer Healthcare Llc | FVIII site-specific modification |
KR20100040840A (ko) | 2007-06-06 | 2010-04-21 | 도만티스 리미티드 | 폴리펩티드,항체 가변 도메인 및 길항제 |
CA2720610C (en) | 2008-04-07 | 2016-08-23 | Bayer Healthcare Llc | Methods of recombinant production of glycoproteins |
KR101005967B1 (ko) * | 2008-04-12 | 2011-01-05 | (주)셀트리온 | 우수한 재조합 단백질을 생산하기 위한 인간 숙주 세포 |
US9090948B2 (en) | 2008-09-30 | 2015-07-28 | Abbott Molecular Inc. | Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples |
DK2440653T3 (en) * | 2009-06-10 | 2019-03-18 | Bts Res International Pty Ltd | Methods for generating hybrid / chimeric cells and their applications |
US11401514B2 (en) | 2016-07-19 | 2022-08-02 | Brandeis University | Compositions and methods for identifying RNA binding polypeptide targets |
CN112118869B (zh) | 2018-05-16 | 2024-10-25 | 莫佛塞斯公司 | 靶向糖蛋白vi的抗体 |
WO2020182974A1 (en) | 2019-03-14 | 2020-09-17 | Morphosys Ag | Antibodies targeting c5ar |
JP2022543522A (ja) * | 2019-06-10 | 2022-10-13 | チョー プラス インコーポレイティド | タンパク質ベースの医薬品の高レベル生産のための細胞株 |
US20230357398A1 (en) | 2020-09-24 | 2023-11-09 | Morphosys Ag | Novel human antibodies binding to human cd3 epsilon |
CN113604425B (zh) * | 2021-06-22 | 2022-10-18 | 中山康天晟合生物技术有限公司 | 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
US6136599A (en) * | 1998-12-10 | 2000-10-24 | Bayer Corporation | Human hybrid host cell for mammalian gene expression |
-
1998
- 1998-12-10 US US09/209,920 patent/US6136599A/en not_active Expired - Lifetime
-
1999
- 1999-08-12 UA UA2001074776A patent/UA77642C2/uk unknown
- 1999-12-08 TR TR2001/01642T patent/TR200101642T2/xx unknown
- 1999-12-08 SK SK791-2001A patent/SK287888B6/sk not_active IP Right Cessation
- 1999-12-08 CZ CZ20012023A patent/CZ302677B6/cs not_active IP Right Cessation
- 1999-12-08 AT AT99963067T patent/ATE306547T1/de active
- 1999-12-08 PL PL349625A patent/PL205549B1/pl unknown
- 1999-12-08 KR KR1020017007224A patent/KR100627753B1/ko active IP Right Grant
- 1999-12-08 ES ES99963067T patent/ES2249929T3/es not_active Expired - Lifetime
- 1999-12-08 EP EP99963067A patent/EP1137768B1/en not_active Expired - Lifetime
- 1999-12-08 RO ROA200100648A patent/RO121563B1/ro unknown
- 1999-12-08 BR BRPI9916095A patent/BRPI9916095B8/pt not_active IP Right Cessation
- 1999-12-08 CN CNB998142999A patent/CN1230532C/zh not_active Expired - Lifetime
- 1999-12-08 WO PCT/US1999/029332 patent/WO2000034462A1/en active IP Right Grant
- 1999-12-08 ID IDW00200101235A patent/ID30448A/id unknown
- 1999-12-08 JP JP2000586896A patent/JP4332300B2/ja not_active Expired - Lifetime
- 1999-12-08 DE DE69927707T patent/DE69927707T2/de not_active Expired - Lifetime
- 1999-12-08 IL IL14335199A patent/IL143351A0/xx unknown
- 1999-12-08 DK DK99963067T patent/DK1137768T3/da active
- 1999-12-08 AU AU19383/00A patent/AU757188B2/en not_active Expired
- 1999-12-08 RU RU2001119161/13A patent/RU2228355C2/ru active
- 1999-12-08 SI SI9920096A patent/SI20693B/sl active Search and Examination
- 1999-12-08 HU HU0104681A patent/HU229775B1/hu unknown
- 1999-12-08 CA CA2353698A patent/CA2353698C/en not_active Expired - Lifetime
-
2001
- 2001-05-24 IL IL143351A patent/IL143351A/en not_active IP Right Cessation
- 2001-06-06 BG BG105566A patent/BG65263B1/bg unknown
- 2001-06-07 NO NO20012806A patent/NO330548B1/no not_active IP Right Cessation
- 2001-06-07 CU CU20010130A patent/CU23382A3/es not_active IP Right Cessation
-
2002
- 2002-08-26 CU CU20020182A patent/CU23238A1/es unknown
-
2009
- 2009-03-06 JP JP2009053279A patent/JP5508740B2/ja not_active Expired - Lifetime
-
2014
- 2014-02-24 JP JP2014032748A patent/JP5826311B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID30448A (id) | Sel induk hibrid manusia untuk mengekspresikan gen mamalia | |
Tjian et al. | Biological activity of purified simian virus 40 T antigen proteins. | |
Manuri et al. | piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies | |
Choi et al. | Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells | |
RU2003131342A (ru) | Способы культивирования цирковирусов | |
KR20120038531A (ko) | 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법 | |
EP1100878B8 (de) | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen | |
JP2021512618A (ja) | 閉鎖系におけるcar−t細胞の製造方法 | |
Macdonald | Development of new cell lines for animal cell biotechnology | |
JPH04228066A (ja) | 外来遺伝子発現用培養細胞 | |
KR100255228B1 (ko) | 글리코프로테인을 발현시키는 포유류 세포계 및 글리코프로테인의 제조 방법 | |
CN104342454A (zh) | 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用 | |
NZ512235A (en) | Human hybrid host cell for mammalian gene expression | |
DK0870044T3 (da) | Reguleret proteinekspression i stabilt transfekterede pattedyrsceller | |
CN109762820A (zh) | 一种骨髓间充质干细胞特异性启动元件在干细胞中的应用 | |
JP2500384B2 (ja) | 生理活性物質の製造法 | |
Bayley et al. | Immortalization of rat keratinocytes by transfection with polyomavirus large T gene | |
Hohenwarter et al. | Human endothelial cell lines established by mutated forms of the simian virus 40 large T oncogene | |
Waldman et al. | Transfer of herpes simplex virus thymidine kinase synthesized in bacteria by a high-expression plasmid to tissue culture cells by protoplast fusion | |
JPH0732705B2 (ja) | 動物細胞増殖用組成物およびそれを用いる動物細胞の増殖方法 | |
Al et al. | Optimization of Human Antibody Production by Xenohybridization of EBV-Transformed Cell Lines | |
Ber et al. | Phenotypic trait transferred by cybridization | |
AU666800B2 (en) | Process for producing exogenous protein | |
JPH0561907B2 (sl) | ||
Thompson | Developments in Biological Standardisation. Volume 72: Progress in Animal Retroviruses: Editors, D. Gaudry and W. Hennessen, Karger, Basel, Switzerland, 1990, ISBN 3-8055-5271-8,£ 91.30 |